RapidAI
CA - Menlo ParkBiotechnology
Focus: RapidAI develops CT and MRI blood flow visualization technology focused on neurology applications. The company is a Series C+ stage biotech operating in the medical device/software space with a presence in Menlo Park, CA.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
Funding Stage
SERIES C +
Open Jobs
7+2 this month
Stable — net +2 jobs in 30d
5 added, 3 removed. Backfill posture.
Should You Work at RapidAI?
AI assessmentRapidAI is a specialized early-stage imaging biotech with emerging commercial traction but limited public visibility into financials, clinical validation, or growth trajectory—suitable for risk-tolerant candidates betting on a focused neurology diagnostic platform.
Why Work Here
- Early-stage Series C+ company with capital backing to execute on neurology imaging platform—meaningful upside potential for early employees
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for RapidAI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.